title: Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
authors: The Johns Hopkins University School of Medicine, Behavioral Biology Research Center, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. mstitzer@jhmi.edu
authors: Maxine L
authors: ML
authors: Stitzer
mesh_terms: D002047:Buprenorphine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008691:Methadone / Q000009:adverse effects; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics / Q000009:adverse effects; D009357:Neonatal Abstinence Syndrome / Q000209:etiology; D058850:Opiate Substitution Treatment / Q000379:methods*; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D009292:Narcotic Antagonists; D009294:Narcotics; D002047:Buprenorphine; D009271:Naltrexone; D008691:Methadone